Live feed16:11:18·372dINSIDERFilingvia QuantisnowChief Financial Officer Ogden Christopher sold $33,381 worth of shares (12,255 units at $2.72) and converted options into 37,500 shares, increasing direct ownership by 13% to 226,271 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CTMX· CytomX Therapeutics Inc.Health CareOriginal source